Select Committee on Science and Technology Written Evidence


Memorandum from the University of Edinburgh

  The University of Edinburgh:

    1.  supports strongly an increased emphasis on translating NIMR science into improved prevention, diagnosis and treatment of ill health;

    2.  advises that the surest prospect for adding translational value to NIMR's excellent basic research is to co-locate with a university/university hospital (we have recently raised over £90 million to co-locate over 800 biomedical bench scientists with the new Royal Infirmary of Edinburgh);

    3.  believes that the status quo is not acceptable, since MRC is already foregoing added value from its very considerable annual investment in NIMR at the isolated Mill Hill site;

    4.  remains concerned that the case for productive synergy between some of the main groupings in NIMR (eg between Infection/Immunity and Neurosciences) has yet to be made, since this is the key argument against relocation to more than one site;

    5.  does not share the Task Force's view that relocation to central London is less likely to risk loss of outstanding staff than relocation elsewhere; and

    6.  concludes that MRC should not limit relocation options to central London, seeking instead "added added value" from co-location with (a) university hospital site(s) where MRC already has major investment.

22 November 2004

previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2005
Prepared 8 February 2005